|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01526 RICI HEALTH
Nominal 
0.870 +0.030 (+3.571%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 2,795,553 | -4.408% | 2,924,457 | 2,992,689 | 2,375,027 | 2,506,522 |
| Cost of Sales | (1,588,193) | -9.592% | (1,756,698) | (1,743,180) | (1,447,825) | (1,607,397) |
| Gross Profit | 1,207,360 | 3.391% | 1,167,759 | 1,249,509 | 927,202 | 899,125 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (12,304) | -67.249% | (37,568) | (9,042) | 3,448 | (1,801) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (93) | -- | 405 | 958 | 419 | 803 | |
| Profit / (Loss) before Taxation | 567,339 | 17.238% | 483,921 | 545,632 | 327,190 | 227,477 | |
| Taxation | (184,311) | 42.583% | (129,266) | (143,657) | (84,041) | (101,372) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | 24,038 | -- | |
| Non-controlling Interests | (75,900) | 32.382% | (57,334) | (38,172) | 23,606 | 55,448 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 307,128 | 3.298% | 297,321 | 363,803 | 290,793 | 181,553 | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 97,646 | -21.240% | 123,979 | 112,246 | 104,907 | 156,706 |
| Depreciation & Amortisation | 418,974 | -2.406% | 429,303 | 396,838 | 340,803 | 384,511 |
| Directors' Emoluments | -- | -- | 3,611 | 3,654 | 6,105 | 8,489 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 19.000 | 0.000% | 19.000 | 23.000 | 18.000 | 11.000 |
| DPS (cts) | 1.767 | -- | 4.156 | 11.995 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 9.301% | -- | 21.873% | 52.151% | -- | -- |
| Cash flow per share ($) | -- | -- | 0.497 | 0.520 | 0.444 | 0.428 |
| NBV per share ($) | 1.035 | -- | 0.846 | 0.709 | 0.600 | 0.426 |
| Remarks: | Real time quote last updated: 27/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 307,128 |
| %Change | 3.298% |
| EPS / (LPS) | RMB 0.190 |
| NBV Per Share (¥) | RMB 1.035 |